CathConnect

CathConnect

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

CathConnect is addressing a significant unmet need in hospital patient safety: traumatic urinary catheter removal. Their simple, in-line device transforms a standard Foley catheter into a safer system by disconnecting before excessive force causes urethral damage. The company, spun out from the University of Washington, has developed the solution through extensive clinician collaboration and internal testing. It is positioned to reduce hospital stays, lower treatment costs, and improve patient outcomes associated with this frequent complication.

UrologyPatient Safety

Technology Platform

A mechanical in-line safety device for Foley catheters that disconnects under excessive pull force to prevent traumatic urethral injury, designed for easy reconnection.

Opportunities

The device addresses over 450,000 costly traumatic removal incidents annually in the US, representing a multi-billion dollar burden to the healthcare system.
Successful adoption could establish a new standard of care in patient safety for millions of catheterized patients, driven by compelling hospital cost savings and improved outcomes.

Risk Factors

Key risks include regulatory hurdles in obtaining FDA clearance, the need to prove clinical efficacy and cost savings in real-world studies, and challenges in driving hospital adoption against established protocols.
Competition from large, incumbent medical supply companies is a persistent threat.

Competitive Landscape

The market for urinary catheter safety devices appears nascent with no dominant player, positioning CathConnect as a pioneer. However, large medical device conglomerates with existing urology/hospital supply portfolios (e.g., BD, Teleflex) possess the resources to rapidly develop or acquire competing solutions if the market proves viable.